Is Canopy Growth Corp (CGC) Stock at the Top of the Drug Manufacturers

Canopy Growth Corp (CGC) is near the middle in its industry group according to InvestorsObserver. CGC gets an overall rating of 27. That means it scores higher than 27 percent of stocks. Canopy Growth Corp gets a 41 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 140 out of 148 industries.

CGC has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on CGC!

See Full CGC Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 27 would rank higher than 27 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Canopy Growth Corp Stock Today?

Canopy Growth Corp (CGC) stock is trading at $2.77 as of 3:17 PM on Friday, Sep 30, a decline of -$0.01, or -0.51% from the previous closing price of $2.78. The stock has traded between $2.73 and $2.88 so far today. Volume today is less active than usual. So far 3,513,543 shares have traded compared to average volume of 9,346,476 shares. Click Here to get the full Stock Report for Canopy Growth Corp stock.